Preparation and characterization of dextran magnetite-incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness.
OBJECTIVE
Dextran magnetite (DM)-incorporated thermosensitive liposomes, namely thermosensitive magnetoliposomes (TMs), were prepared and characterized in order to investigate their possibility for magnetic drug targeting.


METHODS
TMs containing calcein were prepared at various DM concentrations by reverse-phase evaporation of dipalmitoylphosphatidylcholine (DPPC). They were evaluated for their physicochemical properties including size, DM capture, magnetite distribution within liposomes, and temperature-dependent calcein release. Moreover, a novel on-line flow apparatus with a sample injector, a coil of tubing placed in an electromagnet, and a fluorescence detector was developed for quantifying the magnetic responsiveness of TMs. This device allowed us a real-time measurement of percentage holding of TMs by magnetic field.


RESULTS
Due to water-soluble property of DM, higher contents of magnetite up to 490 mg per mmol DPPC were successfully incorporated into the liposomes with DM than with conventional magnetite (Fe3O4). Thermosensitivity and lipid integrity of TMs were not influenced by inclusion of DM. Using the on-line flow system, percentage holding of TMs by magnetic field was shown to vary with several factors; it increases as the magnetic field strength increases, the fluid flow rate decreases, the magnetite content increases, and the liposome concentration increases. Typically, at 490 mg incorporated magnetite per mmol DPPC, 0.5 ml/min-fluid flow rate, and high magnetic field strength (> or = 10 kiloGauss), approximately 100% of TMs were found to be held.


CONCLUSIONS
The TMs were suggested to be useful in future cancer treatment by magnetic targeting combined with drug release in response to hyperthermia.
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000737:chemistry; D002152:Calorimetry, Differential Scanning; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003911:Dextrans / Q000008:administration & dosage / Q000737:chemistry*; D052203:Ferrosoferric Oxide; D005452:Fluoresceins / Q000737:chemistry; D007501:Iron / Q000008:administration & dosage / Q000737:chemistry*; D008081:Liposomes; D008280:Magnetics; D008854:Microscopy, Electron; D008863:Microspheres; D009862:Online Systems; D010087:Oxides / Q000008:administration & dosage / Q000737:chemistry*; D010758:Phosphorus / Q000737:chemistry; D013696:Temperature
D003911:Dextrans; D005452:Fluoresceins; D008081:Liposomes; D010087:Oxides; D015060:1,2-Dipalmitoylphosphatidylcholine; D010758:Phosphorus; D007501:Iron; C007740:fluorexon; D052203:Ferrosoferric Oxide